BeyondSpring Inc. (BYSI) Live Share Price, Invest From India

BeyondSpring Inc. Stock Performance

as on August 1, 2026 at 2:15 pm IST

Day's Low
Day's High
$1.16
Day's Price Range
$1.20
$1.15
-0.87%
Downside
4.35%
Upside
52 Week's Low
52 Week's High
$0.99
52-Week Price Range
$2.44
$1.15
13.57%
Downside
112.17%
Upside

BeyondSpring Inc. share price movements today

Previous Close: $1.13
Open: $1.18
Volume: 142.8K
Day's Low - High: $1.16 - $1.20
52 Week Low - High: $0.99 - $2.44

BeyondSpring Inc. Historical Returns

1 Month Return: -38.5 %
3 Month Return: -22.82 %
1 Year Return: -44.44 %
3 Year Return: + 11.65 %
5 Year Return: -87.87 %

BeyondSpring Inc. Stock Fundamentals & Key Indicators

Check BeyondSpring Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$46.5M

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-8.5M

Revenue (TTM)

1.9M

Profit Margin

0.00%

Return On Equity TTM

-310.48%

BeyondSpring Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of BeyondSpring Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
BeyondSpring Inc.	BUY	$46.5M	-87.87%	NA	0.00%	NA
Revolution Medicines Inc.	BUY	$40.9B	539.16%	NA	0.00%	NA
Vertex Pharmaceuticals Inc.	BUY	$122.3B	140.57%	28.66	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$76.0B	32.14%	16.98	29.65%	NA

Stock Returns calculator for BeyondSpring Inc. Stock including INR - Dollar returns

The BeyondSpring Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

BeyondSpring Inc. investment value today

Current value as on today

₹60,742

Returns

-₹39,258

(-39.26%)

Returns from BeyondSpring Inc. Stock

-₹44,444 (-44.44%)

Dollar Impact

₹5,187 (+5.19%)

Analyst Recommendation on BeyondSpring Inc. Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for BeyondSpring Inc.. Average target price of $1.25

BeyondSpring Inc. Share Price Target

Get share price movements and forecasts by analysts on BeyondSpring Inc..

What analysts predicted

8%UPSIDE

Target Price

$1.25

Current Price

$1.15

Analyzed by

7 Analysts

Target

$1.25

BeyondSpring Inc. target price $1.25, a slight upside of 8% compared to current price of $1.15. According to 7 analysts rating.

BeyondSpring Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	0	0	0	-1	-1	-	-	-	-	-
Gross Profit	0	0	0	-1	-1	0	-	0	0	0
Operating Income	-6	-3	-3	0	-1	-2	-1	-1	-2	-2
EBITDA	-6	-3	-3	0	-1	-2	-1	-1	-2	-2
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	0	0	0	0	0	0	0	0	0
Income Before Tax	-6	-3	-3	0	-1	-2	-1	-1	-2	-2
Income Tax Expense	0	0	0	-	0	0	0	0	0	0
Net Income	-6	-3	-3	-2	-1	4	-1	-1	-2	-2
Net Profit Margin	-1453.71%	-726.20%	-726.20%	213.20%	120.24%	0.00%	0.00%	0.00%	0.00%	0.00%

BeyondSpring Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	0	1	1	1	-	-
Gross Profit	0	0	0	0	0	1	1	0	0	0
Operating Income	-12	-97	-57	-40	-64	-66	-37	-15	-8	-8
EBITDA	-12	-97	-57	-40	-63	-64	-34	-13	-8	-8
Interest Expense	0	1	0	0	0	0	0	-	-	-
Depreciation	-	0	0	0	0	0	0	0	0	0
Income Before Tax	-12	-96	-57	-40	-63	-64	-36	-13	-8	-8
Income Tax Expense	0	-6	-2	-2	-2	3	0	0	0	0
Net Income	-12	-91	-54	-38	-60	-64	-33	-21	-11	-7
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	-33873.89%	-4750.48%	-2463.29%	-1200.80%	0.00%	0.00%

BeyondSpring Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-4	-3	-2	-5	-2	-1	-1	-2	-2
Operating Cash Flow	-5	-6	-5	-16	-4	-5	-4	-5	-3
Investing Cash Flow	-	-	-	-12	6	10	1	-5	4
Financing Cash Flow	-	-	21	26	-	-	0	2	-4
Change in Cash	12	-4	14	-7	-35	4	2	-4	-3

BeyondSpring Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-96	-57	-38	-63	-68	-36	-21	-11	-8
Operating Cash Flow	-28	-39	-48	-43	-47	-28	-16	-16	-20
Investing Cash Flow	-3	2	10	0	-20	18	0	-12	13
Financing Cash Flow	47	13	70	117	0	3	0	26	2
Change in Cash	15	-23	32	73	-67	-7	-16	-1	4

Global Institutional Holdings in BeyondSpring Inc.

Funds	Holdings
Jane Street Group LLC	0.03%
Tanaka Capital Management Inc	0.06%
Vanguard Global Advisers, LLC	0.01%
Steward Partners Investment Advisory, LLC	0%
Decheng Capital LLC	9.24%

See all

Insights on BeyondSpring Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 472.1% return, outperforming this stock by 460.4%
NO EFFECT
Against Peers
In the last 1 year, Revolution Medicines, Inc. Common Stock has given 412.0% return, outperforming this stock by 456.4%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 3 quarters, 500.0K → -1.43M (in $), with an average decrease of 171.9% per quarter
NEGATIVE IMPACT
Price Dip
In the last 1 month, BYSI stock has moved down by -38.5%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 3 quarters, -1.54M → -2.15M (in $), with an average decrease of 19.9% per quarter

About BeyondSpring Inc.

BeyondSpring Inc., a clinical stage biopharmaceutical company, focuses on developing and selling clinical-stage biopharmaceutical therapies focused on oncology and immunology. The company operates through two segments: the Plinabulin pipeline and the TPD platform. The company's lead asset is Plinabulin, a selective immunomodulating microtubule-binding agent that has completed Phase III clinical trials for treatment of non-small cell lung cancer (NSCLC); and as an anti-cancer agent, as well as for the prevention of chemotherapy-induced neutropenia (CIN). It also develops Plinabulin in combination with Plinabulin+docetaxel vs. docetaxel alone for the treatment of NSCLC and epidermal growth factor receptor wild type. In addition, the company develops Plinabulin in combination with various immuno-oncology agents and chemotherapy and radiation; nivolumab, a PD-1 antibody that has completed phase 1 clinical trials for the treatment of non-small cell lung cancer; ipilimumab, a CTLA-4 antibody for the treatment of extensive-stage small cell lung cancer (ES-SCLC); in combination with PD-1 or PD-L1 antibodies and radiation for the treatment of various cancers; and pembrolizumab, etoposide, and platinum to treat extensive-stage small cell lung cancer. Further, it engages in the development of three small-molecule immune agents in preclinical stages; and a drug discovery platform to develop therapeutic agents from internal research and development efforts and from collaboration. The company was founded in 2010 and is headquartered in Florham Park, New Jersey.

Organisation	BeyondSpring Inc.
Headquarters	100 Campus Drive, Florham Park, NJ, United States, 07932
Industry	Biotechnology
CEO	Mr. Min Qiu
E-voting on shares	Click here to vote

Key Management of BeyondSpring Inc.

Name	Title
Dr. Lan Huang Ph.D.	Co-Founder & Chair of the Board
Dr. June Lu Ph.D.	Chief Scientific Officer
Mr. Min Qiu	Chief Executive Officer
Ms. Li Na	Chief Financial Officer
Stephen Kilmer	Head of Investor Relations
Dr. John Mao Ph.D.	Senior Vice President of Development
Ms. Joy Jia	Vice President of Finance

FAQs

What is BeyondSpring Inc. share price today?

BeyondSpring Inc. share price today is $1.15 as on August 1, 2026 at 8:45 am IST at the close of the market. BeyondSpring Inc. share today touched a day high of $1.20 and a low of $1.16.

What is the 52 week high and 52 week low for BeyondSpring Inc. share?

BeyondSpring Inc. share touched a 52 week high of $2.44 on December 12, 2025 and a 52 week low of $0.99 on July 23, 2026. BeyondSpring Inc. stock price today i.e. August 1, 2026 at 8:45 am IST is closed at $1.15,which is 52.87% down from its 52 week high and 15.69% up from its 52 week low.

What is BeyondSpring Inc.'s market capitalisation today?

BeyondSpring Inc. market capitalisation is $0.00T as on August 1, 2026 at 8:45 am IST.

How to invest in BeyondSpring Inc. Stock (BYSI) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for BeyondSpring Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in BeyondSpring Inc. Shares that will get you 1.3043 shares as per BeyondSpring Inc. share price of $1.15 per share as on August 1, 2026 at 8:45 am IST.

What is the minimum amount required to buy BeyondSpring Inc. Stock (BYSI) from India?

Indian investors can start investing in BeyondSpring Inc. (BYSI) shares with as little as ₹95.39 or $1 (as of August 2, 2026 at 2:42 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹953.90 in BeyondSpring Inc. stock (as per the Rupee-Dollar exchange rate as on August 2, 2026 at 2:42 pm IST). Based on BeyondSpring Inc. share’s latest price of $1.15 as on August 1, 2026 at 8:45 am IST, you will get 8.6957 shares of BeyondSpring Inc.. Learn more about fractional shares .

What are the returns that BeyondSpring Inc. has given to Indian investors in the last 5 years?

BeyondSpring Inc. stock has given -87.87% share price returns and 28.64% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?